SecSonar.com

Addex Therapeutics Ltd (ADXN)

Addex Therapeutics Ltd at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Addex Therapeutics Ltd (ADXN) is a Biotechnology company based in CH with a market capitalization of $5M. Revenue declined 92.6% year-over-year and free cash flow was negative at -$2.1M. This page tracks ADXN's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

CH · 2 employees · IPO Feb 12, 2020

Valuation

Valuation & price

$6.60 · as of May 26, 2026 · -39.7% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

—

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$10.13$7.93$5.72Jul 25Dec 25Jul 26Jul 7, 25$9.48Jul 9, 25$9.29Jul 11, 25$8.83Jul 15, 25$9.00Jul 17, 25$8.59Jul 21, 25$8.12Jul 23, 25$8.37Jul 25, 25$8.57Jul 29, 25$8.14Jul 31, 25$8.20Aug 4, 25$8.13Aug 6, 25$8.15Aug 11, 25$7.85Aug 13, 25$7.54Aug 15, 25$7.94Aug 19, 25$8.73Aug 21, 25$8.73Aug 25, 25$7.90Aug 27, 25$7.90Aug 29, 25$7.90Sep 3, 25$8.09Sep 5, 25$8.09Sep 9, 25$7.75Sep 11, 25$8.78Sep 16, 25$9.36Sep 18, 25$10.13Sep 22, 25$9.66Sep 24, 25$9.24Sep 26, 25$8.94Sep 30, 25$9.46Oct 2, 25$9.39Oct 6, 25$9.02Oct 8, 25$9.27Oct 10, 25$9.44Oct 14, 25$8.52Oct 16, 25$8.53Oct 21, 25$9.25Oct 23, 25$9.85Oct 27, 25$9.92Oct 29, 25$9.47Oct 31, 25$9.11Nov 4, 25$9.40Nov 6, 25$8.76Nov 10, 25$8.52Nov 12, 25$8.81Nov 14, 25$8.47Nov 18, 25$8.96Nov 20, 25$7.90Nov 25, 25$7.30Nov 28, 25$7.66Dec 2, 25$8.05Dec 4, 25$8.38Dec 8, 25$8.05Dec 10, 25$7.59Dec 12, 25$8.10Dec 16, 25$7.56Dec 18, 25$7.81Dec 22, 25$8.44Dec 24, 25$8.20Dec 29, 25$7.68Jan 2, 26$8.09Jan 6, 26$8.09Jan 8, 26$7.80Jan 12, 26$8.23Jan 14, 26$8.21Jan 16, 26$8.33Jan 21, 26$8.30Jan 23, 26$8.00Jan 27, 26$7.98Jan 29, 26$8.24Feb 2, 26$7.66Feb 4, 26$7.67Feb 9, 26$8.00Feb 11, 26$7.72Feb 13, 26$7.54Feb 18, 26$7.32Feb 20, 26$7.21Feb 24, 26$7.25Feb 26, 26$6.99Mar 2, 26$7.28Mar 4, 26$7.12Mar 6, 26$7.17Mar 10, 26$7.20Mar 12, 26$7.26Mar 17, 26$6.88Mar 19, 26$5.83Mar 23, 26$6.22Mar 25, 26$6.51Mar 27, 26$6.70Mar 31, 26$6.29Apr 2, 26$5.72Apr 7, 26$6.10Apr 9, 26$6.99Apr 13, 26$6.60Apr 15, 26$7.00Apr 17, 26$6.72Apr 22, 26$6.60Apr 24, 26$7.00Apr 28, 26$6.74Apr 30, 26$6.96May 4, 26$6.93May 6, 26$6.85May 8, 26$6.84May 12, 26$6.70May 14, 26$6.81May 18, 26$6.83May 20, 26$6.78May 22, 26$6.83May 28, 26$6.82Jun 1, 26$6.65Jun 3, 26$6.40Jun 5, 26$5.86Jun 9, 26$6.23Jun 11, 26$6.20Jun 15, 26$6.00Jun 17, 26$6.21Jun 22, 26$6.52Jun 24, 26$6.00Jun 26, 26$6.07Jul 2, 26$5.79
$5.6652-week range$10.95
Loading valuation history…

Fundamentals

Key fundamentals

$5M

Market cap

-92.6%

Revenue growth (YoY)

100.0%

Gross margin

-$2.1M

Free cash flow (USD)

-$1.6M

Net debt

Net cash position

14.4%

Share dilution

1/4

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$17.3KFY 2017$499.9KFY 2018$6.0MFY 2019$2.8MFY 2020$3.6MFY 2021$2.9MFY 2022$1.4MFY 2023$1.6MFY 2024$404.1KFY 2025$30.0K
$17.3K$30K

Free cash flow by year

2016 → 2025

FY 2016$-2.7MFY 2017$-2.1MFY 2018$1.7MFY 2019$-9.5MFY 2020$-12.2MFY 2021$-14.7MFY 2022$-16.4MFY 2023$-8.0MFY 2024$-5.4MFY 2025$-2.1M
-$2.7M-$2.1M

Gross margin by year

2021 → 2025

FY 2021100.0%FY 2022100.0%FY 2023100.0%FY 2024100.0%FY 2025100.0%
100.0%100.0%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last reported: Jun 25, 2026 (EPS $-1.48)

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • Annual reportAnnual Report FiledJun 30, 2026Filing
  • Annual reportAnnual Report FiledJun 25, 2026Filing
  • 6-K filingAnnual General Meeting AnnouncementJun 5, 2026Filing
  • Annual report20-F FiledMay 15, 2026Filing
  • Annual reportAnnual Report FiledApr 30, 2026Filing
  • 6-K filingPress ReleaseApr 29, 2026Filing
  • 6-K filingClinical Study UpdateApr 23, 2026Filing
  • 6-K filingPress ReleaseApr 21, 2026Filing

Questions

Frequently asked questions

What is Addex Therapeutics Ltd's market cap?

Addex Therapeutics Ltd (ADXN) has a market capitalization of $5M.

What is ADXN's P/E ratio?

A meaningful P/E ratio is not available for ADXN — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

When did Addex Therapeutics Ltd last report earnings?

ADXN last reported earnings on June 25, 2026; the next date is not yet scheduled.

Are insiders buying ADXN stock?

SEC Form 4 filings show no open-market insider buys at Addex Therapeutics Ltd in the last 90 days (0 sells).

Same arena

Related companies in Biotechnology

CLGN

CollPlant Biotechnologies Ltd.

$5M

PULM

Pulmatrix, Inc.

$5M

BCAB

BioAtla, Inc.

$5M

APM

Aptorum Group Limited

$5.3M

BRTX

BioRestorative Therapies, Inc.

$4.6M

MTNB

Matinas BioPharma Holdings, Inc.

$4.5M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.